J
Juan Pablo Torres
Researcher at University of Chile
Publications - 95
Citations - 3592
Juan Pablo Torres is an academic researcher from University of Chile. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 27, co-authored 78 publications receiving 2933 citations. Previous affiliations of Juan Pablo Torres include University of Texas Southwestern Medical Center.
Papers
More filters
Journal ArticleDOI
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
Miguel Divo,Claudia Cote,Juan Pablo Torres,Ciro Casanova,Jose M. Marin,Victor Pinto-Plata,Javier J. Zulueta,Carlos Javier Gutiérrez Cabrera,Jorge Zagaceta,Gary M. Hunninghake +9 more
TL;DR: A simple disease-specific comorbidities index (COTE) helps assess mortality risk in patients with COPD and increases in the BODE and COTE were independently associated with increased risk of death.
Journal ArticleDOI
Distance and Oxygen Desaturation During the 6-min Walk Test as Predictors of Long-term Mortality in Patients With COPD
Ciro Casanova,Claudia Cote,Jose M. Marin,Victor Pinto-Plata,Juan Pablo Torres,Armando Aguirre-Jaime,Carlos Vassaux,Bartolome R. Celli +7 more
TL;DR: The 6MWD helps predict mortality primarily in patients with severe COPD and the oxygen desaturation profile during the 6MWT appears to be of less relevance than in other lung diseases and than the resting Pao2.
Journal ArticleDOI
The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
Ciro Casanova,Juan Pablo Torres,Armando Aguirre-Jaime,Victor Pinto-Plata,Jose M. Marin,Elizabeth Cordoba,Rebeca Baz,Claudia Cote,Bartolome R. Celli +8 more
TL;DR: The multidimensional evaluation of COPD should offer insight into response to COPD management and most patients show no statistically significant decline of FEV(1) or increase in BODE.
Journal ArticleDOI
C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD
Juan Pablo Torres,Victor Pinto-Plata,Ciro Casanova,Hanna Mullerova,Elizabeth Córdoba-Lanús,Mercedes Muros de Fuentes,Armando Aguirre-Jaime,Bartolome R. Celli +7 more
TL;DR: In this population of patients with clinically moderate to very severe COPD, the level of CRP level was not associated with survival compared with other prognostic clinical tools such as the BODE index, modified Medical Research Council scale, 6-min walk distance, percentage of predicted FEV, IC/TLC ratio, and Pao(2).
Journal ArticleDOI
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus
Vijay Bhoj,Qinmiao Sun,Elizabeth J. Bhoj,Cynthia Somers,Xiang Chen,Juan Pablo Torres,Asuncion Mejias,Ana M. Gomez,Hasan S. Jafri,Octavio Ramilo,Zhijian J. Chen +10 more
TL;DR: Results provide an example of a normal and effective adaptive immune response in the absence of innate immunity mediated by MAVS and MyD88, and activate a subset of pulmonary dendritic cells that traffic to the draining lymph node in response to RSV.